Novavax Reports Vaccine 90% Effective; Supply Questions Remain
Voice of America
Another highly effective vaccine is poised to join the fight against COVID-19.
But its impact may be blunted by supply issues. The manufacturer expected to produce the bulk of the doses is in India, where the government has banned vaccine exports.
Biotech company Novavax announced Monday that its vaccine was 100% effective in preventing severe cases of COVID-19 and 90% effective in preventing any form of the disease in a clinical trial in the United States and Mexico.
The company has an agreement to sell 350 million doses to COVAX, the World Health Organization-backed program to improve equitable vaccine access globally. It expects to start delivering shots in the third quarter of 2021, pending approval from regulators.
Novavax Reports Vaccine 90% Effective; Supply Questions Remain - New Delhi Times - India s Only International Newspaper newdelhitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newdelhitimes.com Daily Mail and Mail on Sunday newspapers.
Keith Rowley, the prime minister of Trinidad and Tobago, has called for global vaccine distribution based on models of sharing and caring that provide equitable access to small countries like his and benefit of all humankind and not just the privileged, well-heeled few. Carlos Becerra / Anadolu Agency/Getty Images
Originally published on February 21, 2021 9:09 am
Editor s note: This story was updated at 9:55 a.m. ET on Feb. 20 to include a statement provided by email from AstraZeneca.
The Prime Minister of Trinidad and Tobago, Keith Rowley, is not happy about how the global rollout of COVID vaccines is going. He s not happy at all.
Price Check: Nations Pay Wildly Different Prices For Vaccines wfdd.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfdd.org Daily Mail and Mail on Sunday newspapers.